TrademarkDir
IMMUNECYTE
LIVE

Serial Number

90585704

Owner

ImmuneCyte Inc.

Attorney

George T Lyons, III

First Use Date

Mar 17, 2021

Filing Date

Mar 17, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IMMUNECYTE Trademark

Serial Number: 90585704 • Registration: 6638529

IMMUNECYTE is a trademark filed by ImmuneCyte Inc. on March 17, 2021. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ImmuneCyte Inc. (2 trademarks)

Ste 150
Irvine, CA 92618

Entity Type: 03

Trademark Details

Filing Date

March 17, 2021

Registration Date

February 8, 2022

First Use Anywhere

March 17, 2021

First Use in Commerce

March 17, 2021

Published for Opposition

November 23, 2021

Filing History

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 6, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 6, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 6, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 6, 2024 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 16, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 16, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 16, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 16, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 16, 2024 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 7, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Oct 7, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 7, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Feb 8, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 18, 2021 CNSA
ASSIGNED TO EXAMINER
Oct 18, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 17, 2021 NWOS
NEW APPLICATION ENTERED
Mar 20, 2021 NWAP

Related Trademarks

More from this Owner

ACI

ACI